- 客服:
- 电话: 13061953619
- 微信:
EP1013 (F1013) (F1013) 是一种广谱 caspase 选择性抑制剂,用于 1 型糖尿病的研究。
EP1013 is a broad-spectrum caspase selective inhibitor, used in the research of type 1 diabetes.
EP1013 (1, 3, 10 mg/kg) significantly improves marginal islet mass function. Two animals in the 10 mg/kg EP1013 treatment group exhibit primary islet graft nonfunction, but the diabetes reversalrate for this group is not significantly different from the 3 mg/kg EP1013, 1 mg/kg EP1013, or 10 mg/kg zVAD groups. EP1013 therapy enhances functional syngeneic islet mass and promotes longevity of islet graft function[1].
[1]. Emamaullee JA, et al. The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice. Diabetes. 2008 Jun;57(6):1556-66.
动态评分
0.0